APRE earnings
Aprea Therapeutics (APRE) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
- APRE beat EPS estimates in 11 of its last 14 reports.
APRE earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q3 2026 | Nov 4, 2026 | -0.09 | -0.07 | -24.14% | – |
| Q2 2026 | Aug 12, 2026 | -0.07 | -0.18 | 60.56% | – |
| Q1 2026 | May 13, 2026 | -0.22 | -0.23 | 4.35% | $140.50K |
| Q4 2025 | Mar 16, 2026 | -0.32 | -0.38 | 15.79% | $3.34K |
| Q3 2025 | Nov 12, 2025 | -0.47 | -0.11 | -327.27% | $1.85K |
| Q2 2025 | Aug 12, 2025 | -0.53 | -0.77 | 31.17% | $118.11K |
| Q1 2025 | May 14, 2025 | -0.66 | -0.65 | -0.87% | $162.46K |
| Q4 2024 | Mar 25, 2025 | -0.49 | -0.69 | 28.99% | $205.82K |
| Q3 2024 | Nov 7, 2024 | -0.64 | -0.75 | 14.67% | $354.62K |
| Q2 2024 | Aug 12, 2024 | -0.58 | – | – | $561.57K |
| Q1 2024 | May 14, 2024 | -0.67 | -0.78 | 14.10% | $380.57K |
| Q4 2023 | Mar 26, 2024 | -0.92 | – | – | $14.07K |
| Q3 2023 | Nov 9, 2023 | -0.86 | – | – | $319.47K |
| Q2 2023 | Aug 10, 2023 | -0.87 | -1.43 | 39.16% | $249.69K |
| Q1 2023 | May 15, 2023 | -1.34 | -1.51 | 11.26% | – |
| Q4 2022 | Mar 30, 2023 | -0.92 | -2.60 | 64.62% | – |
| Q3 2022 | Nov 9, 2022 | -2.40 | -5.60 | 57.14% | – |